Lite Strategy Inc (LITS) Stock Price, Quote & News

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 858 369 7100

Website: www.litestrategy.com

Address:

9920 Pacific Heights Blvd., Suite 150, San Diego, United States

grtttttteasd May. 12 at 10:11 PM

$LITS is 20% discounted compared to their $LTC.X holdings. When $BTC.X runs $MSTR is typicall 2-3x their $BTC.X holdings Lite strategy can go much higher and much faster than anyone expects. If Litecoin breaks out the gains are going to snowball extremely fast.

0 · Reply

CopyCatInvestmentCorp May. 12 at 7:07 PM

$LITS True value $45 of 1:1 with $MSTR $LTC.X True value $20K $BTC.X Tokenomics: BTC 21M LTC 84M (4x)

0 · Reply

CopyCatInvestmentCorp May. 12 at 4:08 PM

$LITS $LTC.X

0 · Reply

OfficialStocktwitsUser May. 11 at 12:21 PM

$LITS RSI: 53.85, MACD: 0.0028 Vol: 0.03, MA20: 1.16, MA50: 1.16 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

CopyCatInvestmentCorp May. 11 at 3:29 AM

$LITS 👀

0 · Reply

LostSun May. 7 at 2:59 AM

$LITS lol

0 · Reply

BillionerOfKing May. 4 at 10:34 PM

$LITS Current Stock Price: $1.14 Contracts to trade: $2.5 LITS May 15 2026 Call Entry: $0.01 Exit: $0.02 ROI: 94% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

soccerplayer06 May. 1 at 12:15 PM

$LITS Seems like a great time to add to the treasury if possible… $LTC.X time to show some conviction in what you are doing!

0 · Reply

Trendytraders Apr. 7 at 10:50 PM

$LITS $LTC.X don’t sleep

0 · Reply

End00Game Mar. 31 at 10:32 PM

$FOX.X $LTC.X $LITS $ZEC.X So looking at top holders of Lite Strategy it is Citadel and Renaissance . Litecoin is nose diving not sure what is happening here....

1 · Reply

Lite Strategy reports Q2 EPS (82c) vs. (40c) last year

2026-02-17T14:00:57.000Z - 3 months ago

Lite Strategy to continue to evaluate strategic investments in 2H of 2026

Feb 17, 2026, 8:50 AM EST - 3 months ago

Lite Strategy Reports Fiscal 2026 Second Quarter Results

2025-11-19T16:15:44.000Z - 6 months ago

Lite Strategy names acting CEO Justin File to role on a permanent basis

2025-11-17T14:05:45.000Z - 6 months ago

Lite Strategy reports Q1 results, highlights launch of $100M Litecoin Treasury

2025-10-29T13:12:45.000Z - 6 months ago

Lite Strategy announces $25M share repurchase program

2025-10-08T20:50:10.000Z - 7 months ago

Lite Strategy files to sell 780,497 shares of common stock for holders

Sep 10, 2025, 9:00 AM EDT - 8 months ago

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Aug 5, 2025, 8:00 AM EDT - 10 months ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Jul 24, 2025, 8:00 PM EDT - 10 months ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 22, 2025, 4:35 PM EDT - 10 months ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 8:30 AM EDT - 10 months ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

May 13, 2025, 4:05 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 4:12 PM EST - 1 year ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Aug 12, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 1 year ago

MEI Pharma to Consider Strategic Alternatives

May 9, 2024, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Apr 16, 2024, 1:30 PM EDT - 2 years ago

Lite Strategy Transcript: Stifel Virtual Targeted Oncology Days Conference

Apr 11, 2024, 8:02 AM EDT - 2 years ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 10, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

$MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia$

Mar 26, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Feb 13, 2024, 5:05 PM EST - 2 years ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Jan 16, 2024, 5:00 PM EST - 2 years ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Nov 15, 2023, 8:35 AM EST - 2 years ago

Lite Strategy Transcript: The Stifel 2023 Annual Healthcare Conference

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Sep 28, 2023, 5:00 PM EDT - 2 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 26, 2023, 5:00 PM EDT - 2 years ago

Lite Strategy Earnings Call Transcript: Q4 2023

Sep 26, 2023, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 21, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Aug 16, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Jul 23, 2023, 2:30 PM EDT - 3 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 19, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 18, 2023, 9:00 AM EDT - 3 years ago

MEI Pharma Responds to Anson and Cable Car

Jul 17, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 13, 2023, 4:05 PM EDT - 3 years ago

MEI Pharma Postpones Special Meeting of Shareholders

Jul 11, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 5, 2023, 8:30 AM EDT - 3 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 15, 2023, 12:08 PM EDT - 3 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 14, 2023, 7:01 PM EDT - 3 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 13, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

Jun 2, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

Jun 1, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Board of Directors Rejects Unsolicited Proposal

May 30, 2023, 5:40 PM EDT - 3 years ago

MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal

May 23, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies

grtttttteasd May. 12 at 10:11 PM

0 · Reply

CopyCatInvestmentCorp May. 12 at 7:07 PM

$LITS True value $45 of 1:1 with $MSTR $LTC.X True value $20K $BTC.X Tokenomics: BTC 21M LTC 84M (4x)

0 · Reply

CopyCatInvestmentCorp May. 12 at 4:08 PM

$LITS $LTC.X

0 · Reply

OfficialStocktwitsUser May. 11 at 12:21 PM

0 · Reply

CopyCatInvestmentCorp May. 11 at 3:29 AM

$LITS 👀

0 · Reply

LostSun May. 7 at 2:59 AM

$LITS lol

0 · Reply

BillionerOfKing May. 4 at 10:34 PM

0 · Reply

soccerplayer06 May. 1 at 12:15 PM

$LITS Seems like a great time to add to the treasury if possible… $LTC.X time to show some conviction in what you are doing!

0 · Reply

Trendytraders Apr. 7 at 10:50 PM

$LITS $LTC.X don’t sleep

0 · Reply

End00Game Mar. 31 at 10:32 PM

$FOX.X $LTC.X $LITS $ZEC.X So looking at top holders of Lite Strategy it is Citadel and Renaissance . Litecoin is nose diving not sure what is happening here....

1 · Reply

soccerplayer06 Mar. 31 at 4:35 PM

$LITS looks like the company is using that buyback money today. $LTC.X

3 · Reply

Bestbee Mar. 30 at 5:41 PM

$LITS

0 · Reply

Bohrenn Mar. 27 at 2:04 PM

$LITS Wo starke Verlust zu machen sind, darf der Sharedeals.de No Brainer Club nicht fehlen. Daher natürlich auch bei $LITS bereits zu Kursen um 1,40 USD am 02.01.2026 die Empfehlung zum Kauf. Denn gezielte Verarmung ist am nachhaltigsten wenn sie breit diversifiziert erreicht wird. Die besondere Qualität besteht darin auch außerhalb des Kernbereichs verlässliche Verlierer zu identifizieren.

3 · Reply

Prometheus2 Mar. 26 at 11:27 AM

$LITS subtracting today.. Bitcoin’s isomer has no real value. Insane.

0 · Reply

ggabel7 Mar. 24 at 5:42 PM

well well😍 what’s going on here $CRWV $MSFT $LITS $TSEM I can’t believe retails not all over $EVTV great news plenty of juice to be made when volume comes

0 · Reply

soccerplayer06 Mar. 24 at 9:53 AM

$LITS adding more here today. $LTC.X

1 · Reply

soccerplayer06 Mar. 20 at 2:08 PM

$LITS added some more here. huge potential, especially if they announce more litecoin purchases or mining news. $LTC.X

0 · Reply

soccerplayer06 Mar. 18 at 12:00 PM

$LTC.X no volume right now. Could easily go right back up. $LITS

0 · Reply